
CURE spoke with a provider and a survivor about the potential power of minimal residual disease testing.

CURE spoke with a provider and a survivor about the potential power of minimal residual disease testing.

In an interview, liver cancer survivor Charles Walker shared how family support and a living donor transplant changed his treatment journey and outlook.

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for autologous stem cell transplant.

Former NFL player and advocate Chris Draft urges patients with cancer to recognize small actions, learn terms and stay engaged to rebuild confidence after diagnosis.

Colleen Mabasa shared her experience navigating CAR-T cell therapy beyond the clinical aspects of treatment.

In a recent CURE conversation, Charles Walker shared how months of unexplained fatigue and back pain ultimately led to a life-altering diagnosis.

CURE spoke with Dr. Kathie-Ann Joseph about the importance of personalized, multidisciplinary treatments when caring for patients with breast cancer.

Dr. Sue Hwang explains how she went from a care provider who helped others through their cancer journeys to a patient facing a cancer diagnosis of her own.

USC doctors say careful staging and tumor testing help younger patients choose surgery and targeted treatments based on their cancer.

Dr. Elias Obeid says ongoing monitoring after treatment helps detect recurrence early and identify late effects, supporting survivorship for patients.

Dr. Suneel Kamath emphasized the growing importance of understanding biomarkers in patients with gastrointestinal cancers.

Relacorilant plus Abraxane showed benefit without biomarker testing, potentially expanding treatment access for patients with platinum-resistant ovarian cancer.

Dietitians share a fiber- and protein-rich pastina bean soup to help patients with colorectal cancer stay nourished and manage gastrointestinal symptoms during treatment.

World Cancer Day highlights the global impact of cancer, raising awareness, fostering unity and reminding us to support survivors and patients together.

Former U.S. goalkeeper opens up about a large B-cell lymphoma diagnosis and finally reaching remission after chimeric antigen receptor T cell therapy, urging patients to advocate and seek options.

Dr. Joshua K. Sabari explains how surgery, radiation and therapy may reduce lung capacity and shares steps survivors can take to protect their breathing health.

CURE recently spoke with CEPHEUS study investigator Dr. Saad Z. Usmani, chief of the myeloma service at Memorial Sloan Kettering Cancer Center.

A gynecologic oncologist discusses staging, treatment choices, sexual health, mental health and HPV vaccination during cervical cancer awareness month.

Dr. Suneel Kamath addresses patient concerns on the topic of clinical trial participation in the gastrointestinal cancer treatment space.

CURE sat down with Dr. Kathie-Ann Joseph to discuss surgical advancements for individuals with breast cancer.

Minimal residual disease testing can offer psychological comfort to patients and survivors as well as insight into potential treatment strategies for care providers.

Risk assessment helps patients understand why cancer occurred, the role of genetics, treatment options and prevention strategies for themselves and family.

Dr. Suneel Kamath discusses the importance of biomarker-driven approaches in cancer care following the 2026 ASCO GI Symposium.

Dr. Tracy Proverbs-Singh explains that caregivers may neglect screenings, medications, rest, and hydration, risking their own health.

Dr. Tracy Proverbs-Singh explains how a multidisciplinary team helps patients with GI cancers manage digestion, absorb nutrients and maintain energy during treatment.

Dr. Anne Peled shares advice for patients and dispelled myths related to cancer survivorship.

For Ashliann Mazeika, a diagnosis at 24 led to a decade-long treatment journey affirmed by the Breast Cancer Index test.

Dr. Anne Peled co-developed the sensation-preserving mastectomy she received after her second diagnosis of breast cancer.

For Richard “Rocky” Kimball, a diagnosis of myelodysplastic syndromes, or MDS, necessitated a number of lifestyle changes.

Dr. Nicholas Hornstein explained the concept of ctDNA and how this blood test may help guide treatment decisions, including whether additional therapy is needed.